Operating Lease, Payments in USD of Autolus Therapeutics plc from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Autolus Therapeutics plc quarterly/annual Operating Lease, Payments history and change rate from 2019 to 2024.
  • Autolus Therapeutics plc Operating Lease, Payments for the quarter ending 31 Mar 2024 was $1.73M, a 33.1% increase year-over-year.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2024 was $4.26M, a 59.1% decline from 2023.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2023 was $10.4M, a 127% increase from 2022.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2022 was $4.58M, a 0.95% decline from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Autolus Therapeutics plc Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.73M +$429K +33.1% 01 Jan 2024 31 Mar 2024 10-Q 17 May 2024
Q1 2023 $1.3M 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024

Autolus Therapeutics plc Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.26M -$6.15M -59.1% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 $10.4M +$5.83M +127% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 $4.58M -$44K -0.95% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 $4.62M -$277K -5.66% 01 Jan 2021 31 Dec 2021 20-F 07 Mar 2023
2020 $4.9M +$2.48M +103% 01 Jan 2020 31 Dec 2020 20-F 10 Mar 2022
2019 $2.42M 01 Jan 2019 31 Dec 2019 20-F 04 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.